Loading…
Loading…

| 6586.TWO | CHO Pharma, Inc. | NT$111.50 | NT$23.9B |
| 6945.TWO | AP Biosciences Inc | NT$101.50 | NT$9.8B |
| 4162.TWO | PharmaEngine, Inc. | NT$60.10 | NT$8.6B |
| 6976.TWO | Acepodia, Inc. | NT$11.75 | NT$6.8B |
| 1734.TW | Sinphar Pharmaceutical Co. Ltd. | NT$32.50 | NT$6.6B |
| 4157.TWO | TaiGen Biopharmaceuticals Holdings Limited | NT$9.10 | NT$6.5B |
| 4726.TWO | Mycenax Biotech Inc. | NT$24.50 | NT$5.1B |
| 6875.TWO | Pharmosa Biopharm Inc. | NT$33.00 | NT$4.3B |
| 4174.TWO | OBI Pharma, Inc. | NT$26.70 | NT$3.5B |
| 6733.TWO | BioGend Therapeutics Co., Ltd. | NT$26.15 | NT$3.5B |